EUVIMEDAtrasti EUVIMED
Open access · CC BY 4.0

1‐Aryl‐6,7‐Dimethoxy‐3,4‐Dihydroisoquinoline‐2(1 H )‐Sulfonamides as hCA XII Selective Inhibitors: Experimental and Theoretical Studies to Interrogate the Isoform Selectivity

Federico Ricci, Anna Di Fiore, Andrea Angeli iD, Laura De Luca, Francesca Mancuso, Davide Esposito, Giuseppina De Simone, Claudiu T Supuran iD, Rosaria Gitto iD

ChemMedChem · 2026-07-29 · 21 (14)

DOI: 10.1002/cmdc.70390 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-07-23. Written by Federico Ricci and 8 co-authors. Institution: CHIBIOFARAM Department, University of Messina, Messina, Italy. Major MEDLINE topics: Sulfonamides, Carbonic Anhydrase Inhibitors, Carbonic Anhydrases, Isoquinolines. 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministero dell'Istruzione, dell'Università e della Ricerca.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Human carbonic anhydrase XII (hCA XII) represents an important pharmacological target for different types of cancer. hCA XII plays a crucial role in regulating both extracellular and intracellular pH, thereby influencing cancer cell proliferation, invasion, growth, and metastasis. Although the interaction features of hCA inhibitors (hCAIs) with the catalytic site of distinct hCA isoforms are generally well described, the lack of selectivity remains a major challenge. In a previous work, we have reported a series of 1‐aryl‐6,7‐dimethoxy‐3,4‐dihydroisoquinoline‐2(1 H )‐sulfonamides displaying weak activity against the ubiquitous hCA I and hCA II, thus emerging as hCAIs that may be free of unwanted side‐effects. Herein, further evaluation of their CA inhibitory effects allowed to disclose three potent hCA XII inhibitors at low nanomolar concentrations ( K i values ranging from 5.5 to 6.5 nM). Additionally, they showed remarkable isoform selectivity compared with the well‐known inhibitor SLC‐0111, currently in clinical trials as an antitumor agent. Crystallography analyses and computational studies clarified the molecular basis of this behavior and provided valuable insights for the rational design of selective inhibitors targeting hCA XII.

Subjects

MeSH terms (MEDLINE)

SulfonamidesCarbonic Anhydrase InhibitorsCarbonic AnhydrasesIsoquinolinesHumansStructure-Activity RelationshipMolecular Docking SimulationIsoenzymesMolecular StructureDose-Response Relationship, DrugCatalytic Domain

Author keywords

cancercarbonic anhydrasechemistrycrystallographydocking (molecular)drug designextracellularmedicinal chemistryrational design

Substances

SulfonamidesCarbonic Anhydrase InhibitorsCarbonic AnhydrasesIsoquinolinescarbonic anhydrase XIIIsoenzymes

Authors and institutions

  • CHIBIOFARAM Department, University of Messina, Messina, Italy.
  • Institute of Biostructures and Bioimaging, CNR, Napoli, Italy.
  • NEUROFARBA Department, University of Florence, Sesto Fiorentino, Florence, Italy.

ORCID profiles: Andrea Angeli, Claudiu T Supuran, Rosaria Gitto

Funding

  • Ministero dell'Istruzione, dell'Università e della Ricerca

Cite

APA

Ricci, F., Di Fiore, A., Angeli, A., De Luca, L., Mancuso, F., Esposito, D., De Simone, G., Supuran, C. T., & Gitto, R. (2026). 1‐Aryl‐6,7‐Dimethoxy‐3,4‐Dihydroisoquinoline‐2(1 H )‐Sulfonamides as hCA XII Selective Inhibitors: Experimental and Theoretical Studies to Interrogate the Isoform Selectivity. ChemMedChem, 21(14). https://doi.org/10.1002/cmdc.70390

Vancouver

Ricci F, Di Fiore A, Angeli A, De Luca L, Mancuso F, Esposito D, et al. 1‐Aryl‐6,7‐Dimethoxy‐3,4‐Dihydroisoquinoline‐2(1 H )‐Sulfonamides as hCA XII Selective Inhibitors: Experimental and Theoretical Studies to Interrogate the Isoform Selectivity. ChemMedChem. 2026;21(14). doi:10.1002/cmdc.70390

BibTeX
@article{Ricci2026,
  author = {Ricci, Federico and Di Fiore, Anna and Angeli, Andrea and De Luca, Laura and Mancuso, Francesca and Esposito, Davide and De Simone, Giuseppina and Supuran, Claudiu T and Gitto, Rosaria},
  title = {1‐Aryl‐6,7‐Dimethoxy‐3,4‐Dihydroisoquinoline‐2(1 H )‐Sulfonamides as hCA XII Selective Inhibitors: Experimental and Theoretical Studies to Interrogate the Isoform Selectivity},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {14},
  doi = {10.1002/cmdc.70390}
}
Start for free →